News & events

Stroke patient thankful for MSU

11 September 2023

It was Geoff’s young grandson who first noticed that something wasn’t quite right with his grandfather. After his family called triple zero (000), the Mobile Stroke Unit (MSU) was dispatched. (Photo: Herald Sun)

The RMH neurologist receives $2 million to advance MND research and care

04 September 2023

The RMH neurologist and The Florey Institute researcher Dr Thanuja Dharmadasa has received funding for three grants in a record investment from FightMND.

Stroke patient reunited with lifesaving team

08 August 2023

This week is Stroke Week and in a heartfelt reunion, members from our Mobile Stroke Unit (MSU) team were reunited with stroke patient, Sebastian.

Studying effectiveness of AHSCT in highly active relapsing-remitting MS patients

28 July 2023

Researchers from the Royal Melbourne Hospital (RMH) have conducted a ground-breaking study comparing different treatment options for highly active relapsing-remitting multiple sclerosis (MS) patients who have shown limited response to conventional therapies.

A hard act to swallow – how Greg bounced back from a stroke of misfortune

16 March 2023

Greg suffered a major stroke in late 2022, something he understatedly describes as an ‘interesting experience’.

New study finds thrombectomy benefits patients with large ischaemic strokes

13 February 2023

A recent study has shown that endovascular thrombectomy, a minimally invasive procedure that removes blood clots, can improve the outcomes of patients with large ischaemic strokes.

Brain interface proves to be safe and effective

24 January 2023

A device the size of a small paperclip, created to give people with severe paralysis the ability to communicate again, has been shown to be safe.

New study suggests acute stroke treatment is influenced by ethnicity and race

20 July 2022

An international, randomised controlled ischaemic stroke trial DIRECT-SAFE suggests acute stroke treatment should be adapted based on ethnicity and race. 

Severity of MS linked to distance from the equator

03 June 2022

A large international study has found that the severity of multiple sclerosis (MS) can vary depending on latitude, with those living furthest from the equator worse affected by the disease.

World-first clot-busting drug trial improves patient care on Mobile Stoke Unit

09 May 2022

A randomised controlled drug trial suggests clot-busting drug Tenecteplase provides better outcomes for stroke patients compared to the current standard of care alteplase.